Literature DB >> 17212167

Medication therapy in ambulatory medical care: United States, 2003-04.

Saeid Raofi1, Susan M Schappert.   

Abstract

OBJECTIVE: This report describes medication therapy at visits to physician offices, hospital outpatient departments, and emergency departments in the United States during 2003 and 2004. Office-based care is further subdivided into three categories-primary care, surgical specialties, and medical specialties.
METHODS: Data from the 2003 and 2004 National Ambulatory Medical Care Surveys (NAMCS) and National Hospital Ambulatory Medical Care Surveys (NHAMCS) were combined to produce averaged annual estimates of ambulatory medical care utilization.
RESULTS: An estimated 1.9 billion drugs per year were provided, prescribed, or continued at ambulatory care visits in the United States during 2003 and 2004. Two-thirds of the 1.1 billion ambulatory care visits per year included medication therapy. The rate was highest at visits to medical specialists (2.3 drugs per visit). The rate of drugs per visit increased with patient age in each ambulatory care setting. Cardiovascular-renal was the class of drugs most frequently cited at visits to primary care physicians and medical specialists. Pain relievers were the drugs reported most often at hospital emergency and outpatient department visits. Of the 50 drugs most frequently reported overall, three-quarters of them were accounted for by six therapeutic classes-pain relievers, cardiovascular-renal agents, respiratory tract drugs, central nervous system drugs (antianxiety agents and antidepressants), hormonal agents, and antimicrobials. Ibuprofen, aspirin, atorvastatin calcium, acetaminophen, and albuterol were the five most frequently reported medications. From 1993 to 2004, the number of drugs provided, prescribed, or continued per visit increased for all settings.

Entities:  

Mesh:

Year:  2006        PMID: 17212167

Source DB:  PubMed          Journal:  Vital Health Stat 13        ISSN: 0083-2006


  12 in total

1.  Prediction of drug response and safety in clinical practice.

Authors:  Andrew A Monte; Kennon J Heard; Vasilis Vasiliou
Journal:  J Med Toxicol       Date:  2012-03

2.  Antibiotic Prescribing for Children in United States Emergency Departments: 2009-2014.

Authors:  Nicole M Poole; Daniel J Shapiro; Katherine E Fleming-Dutra; Lauri A Hicks; Adam L Hersh; Matthew P Kronman
Journal:  Pediatrics       Date:  2019-01-08       Impact factor: 7.124

3.  Systemic and Local Corticosteroid Use Is Associated with Reduced Executive Cognition, and Mood and Anxiety Disorders.

Authors:  Mesut Savas; Christiaan H Vinkers; Judith G M Rosmalen; Catharina A Hartman; Vincent L Wester; Erica L T van den Akker; Anand M Iyer; Bruce S McEwen; Elisabeth F C van Rossum
Journal:  Neuroendocrinology       Date:  2019-06-21       Impact factor: 4.914

4.  The development of the Washington State emergency department opioid prescribing guidelines.

Authors:  Darin E Neven; Jennifer C Sabel; Donelle N Howell; Russell J Carlisle
Journal:  J Med Toxicol       Date:  2012-12

5.  The role of a prescription in anxiety medication use, abuse, and dependence.

Authors:  Miriam C Fenton; Katherine M Keyes; Silvia S Martins; Deborah S Hasin
Journal:  Am J Psychiatry       Date:  2010-07-01       Impact factor: 18.112

Review 6.  How an age of anxiety became an age of depression.

Authors:  Allan V Horwitz
Journal:  Milbank Q       Date:  2010-03       Impact factor: 4.911

Review 7.  Overtreating chronic back pain: time to back off?

Authors:  Richard A Deyo; Sohail K Mirza; Judith A Turner; Brook I Martin
Journal:  J Am Board Fam Med       Date:  2009 Jan-Feb       Impact factor: 2.657

Review 8.  Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature.

Authors:  Silvia S Martins; Laura Sampson; Magdalena Cerdá; Sandro Galea
Journal:  Am J Public Health       Date:  2015-11       Impact factor: 9.308

9.  Persistent nonmalignant pain management using nonsteroidal anti-inflammatory drugs in older patients and use of inappropriate adjuvant medications.

Authors:  Nahid Rianon; Maureen E Knell; Walter Agbor-Bawa; Joan Thelen; Crystal Burkhardt; Rafia S Rasu
Journal:  Drug Healthc Patient Saf       Date:  2015-01-29

10.  New chronic disease medication prescribing by nurse practitioners, physician assistants, and primary care physicians: a cohort study.

Authors:  Zachary A Marcum; Johanna E Bellon; Jie Li; Walid F Gellad; Julie M Donohue
Journal:  BMC Health Serv Res       Date:  2016-07-27       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.